Ocugen

NASDAQ OCGN
$1.91 0.0000 0.0000%
Today share price
USA
Sector: Healthcare Industry: Biotechnology
Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free

Rating Finrange

Index: 18 %
Market cap

Market capitalization – refers to the total value of all a company's shares of stock. It is calculated by multiplying the price of a stock by its total number of outstanding shares.

491.31M
EV

Enterprise value is a measure of a company's total value, often used as a more comprehensive alternative to equity market capitalization. Enterprise value includes in its calculation the market capitalization of a company but also short-term and long-term debt as well as any cash on the company's balance sheet.

455.23M
Beta

Beta is one of the most popular indicators of risk is a statistical measure. Analysts use this measure often when they need to determine a stock's risk profile.

4.30
Shares

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company’s insiders.

257.23M
YTD

Year to date (YTD) refers to the period of time beginning the first day of the current calendar year or fiscal year up to the current date. he acronym often modifies concepts such as investment returns and price change.

232.17 %

Upcoming events Ocugen

All events
No upcoming events scheduled

Stock chart Ocugen

Stock analysis Ocugen

Indicator Company Industry
P/E (LTM)

Shows how many years the investor's investment in the company will pay off with a profit over the last 12 months.

-8.40 28.84
P/BV (LTM)

Shows the ratio of the market price of the share to the current book value.

12.11 4.35
EV/EBITDA (LTM)

Represents the ratio of the company's value to its pre-tax EBITDA in the last 12 months.

-7.68 10.00
Net Debt/EBITDA (LTM)

A company's debt ratio, which indicates how long the company will need to run on cash flow in the past 12 months to pay off its own debt.

0.61 0.65
ROE (LTM)

Shows the efficiency of using the share capital by the company. In other words, ROE shows how much of the company's net profit for the invested capital over the last 12 months.

-193.33 7.67

Price change Ocugen per year

0.25$ 16.20$
Min Max

Summary analysis Ocugen

Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free

Shareholder structure Ocugen

Revenue and net income Ocugen

All parameters

Stock news Ocugen

All news

Ocugen Shares Rise 9% After OCU500 Inclusion in NIAID Trial

Ocugen Shares Rise 9% After OCU500 Inclusion in NIAID Trial

Ocugen Shares Sink 20% on Public Offering Pricing

Ocugen Shares Sink 20% on Public Offering Pricing

Ocugen Submits IND Application to FDA for Diabetic Macular Edema Treatment

Ocugen Submits IND Application to FDA for Diabetic Macular Edema Treatment

Moderna, CureVac and Ocugen offer updates on COVID vaccines, while China cracks down on critics of government’s pandemic response

Moderna, CureVac and Ocugen offer updates on COVID vaccines, while China cracks down on critics of government’s pandemic response

Ocugen stock up 16% premarket after company announced positive results for its COVID vaccine

Ocugen stock up 16% premarket after company announced positive results for its COVID vaccine

Ocugen Sees Positive Trial Results for Covaxin

Ocugen Sees Positive Trial Results for Covaxin

Ocugen Shares Give Back Wednesday Gains, Drop 10%

Ocugen Shares Give Back Wednesday Gains, Drop 10%

Ocugen Shares Rise 8% After Deal to Commercialize Covid-19 Vaccine

Ocugen Shares Rise 8% After Deal to Commercialize Covid-19 Vaccine

Ocugen, Washington University in Commercialization Deal for Covid Vaccine

Ocugen, Washington University in Commercialization Deal for Covid Vaccine

Ocugen: FDA Lifts Hold on Covid-19 Vaccine Candidate Study >OCGN

Ocugen: FDA Lifts Hold on Covid-19 Vaccine Candidate Study >OCGN

About company Ocugen

Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on the developing gene therapies to cure blindness diseases. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, such as retinitis pigmentosa and leber congenital amaurosis; OCU410, gene therapy candidate for the treatment of dry age-related macular degeneration (AMD); and OCU200, a novel fusion protein that is in preclinical development stage for the treatment of diabetic macular edema, diabetic retinopathy, and wet AMD. Ocugen, Inc. has a strategic partnership with CanSino Biologics Inc. for gene therapy co-development and manufacturing; and Bharat Biotech for the commercialization of COVAXIN in the United States market. The company is headquartered in Malvern, Pennsylvania.
Address:
263 Great Valley Parkway, Malvern, PA, United States, 19355
Company name: Ocugen
Issuer ticker: OCGN
ISIN: US67577C1053
Country: USA
Exchange: NASDAQ
Currency: $
IPO date: 2014-12-03
Sector: Healthcare
Industry: Biotechnology
Site: https://www.ocugen.com

On which stock exchange are Ocugen (OCGN) stocks traded?

Ocugen (OCGN) stocks are traded on NASDAQ.

What is the ticker of Ocugen stocks (OCGN)?

The stock ticker of Ocugen’s stocks or in other words, the code is OCGN. The stocks are currently listed on the NASDAQ exchange.

In which sector and industry does Ocugen (OCGN) operate?

According to the GICS (Global Industry Classification Standard) classification developed jointly by MSCI and Standard & Poor's, Ocugen (OCGN) belongs to the «Healthcare» sector and the «Biotechnology» industry.

In what currency are Ocugen (OCGN) stocks traded?

Ocugen (OCGN) stocks are traded on the NASDAQ exchange in dollars.

What is the price of Ocugen (OCGN) stocks today?

The current price of Ocugen stocks on 20.05.2024 is 1.91 dollars. per share.

What is the dynamics of Ocugen (OCGN) stocks from the beginning of the year?

Ocugen (OCGN) quotes have increased by 190.45% from the beginning of the year up to 1.91 dollars. per 1 stocks.

How much did Ocugen (OCGN) stocks increase in мае 2024?

This month Ocugen (OCGN) quotes have increased by 37.41% to 1.91 dollars. per share.

How much are Ocugen (OCGN) stocks worth?

Today, on October, 20.05.2024 Ocugen’s (OCGN) stocks cost 1.91 dollars..

What is the market capitalization of Ocugen (OCGN)?

Capitalization is the market value of Ocugen (OCGN) is calculated as the number of issued stocks multiplied on the current quotation price. Thus, on 20.05.2024, the market capitalization of Ocugen (OCGN) is estimated at about 491314335 dollars.